Moderna is most shorted stock in S&P 500 as Americans skip jabs
NegativeFinancial Markets

- Moderna has become the most shorted stock in the S&P 500 as public interest in Covid
- This decline in stock value is critical for Moderna as it faces increasing competition and skepticism regarding the future demand for its vaccines. The company's financial health and market position are under scrutiny as it navigates these challenges.
- The broader market context reveals a trend of volatility affecting tech stocks, particularly the Nasdaq, which has also seen significant declines. This environment of uncertainty may further impact investor sentiment towards biotech firms like Moderna, highlighting ongoing concerns about the sustainability of pandemic
— via World Pulse Now AI Editorial System







